WO2025004009 - COMPOSITIONS COMPRISING ISOLATED ENDOTHELIAL PROGENITOR CELLS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/004009
Publication Date
02.01.2025
International Application No.
PCT/IB2024/056371
International Filing Date
28.06.2024
Title **
[English]
COMPOSITIONS COMPRISING ISOLATED ENDOTHELIAL PROGENITOR CELLS AND USES THEREOF
[French]
COMPOSITIONS CONTENANT DES CELLULES PROGÉNITRICES ENDOTHÉLIALES ISOLÉES ET LEURS UTILISATIONS
Applicants **
THE UNIVERSITY OF QUEENSLAND
The University of Queensland
St Lucia, Queensland 4072, AU
Inventors
COLDITZ, Paul
The University of Queensland
St Lucia, Queensland 4072, AU
KHOSROTEHRANI, Kiarash
The University of Queensland
St Lucia, Queensland 4072, AU
KAUR, Simranpreet
The University of Queensland
St Lucia, Queensland 4072, AU
Priority Data
2309945.0
29.06.2023
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP Australia
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 5101 | |
| EPO | Filing, Examination | 76055 | |
| Japan | Filing | 597 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 36860 |
Total: 119188 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present technology comprises isolated endothelial progenitor cell (EPC) populations comprising PROCR+/- PDGFRA+/- EPCs and mesenchymal stem cell (MSC) populations, and methods of making and use thereof in treating hypoxic-ischemic encephalopathy (HIE) or brain injury in a subject.[French]
La présente technologie concerne des populations de cellules progénitrices endothéliales (EPC) isolées contenant des populations d'EPC PROCR+ PDGFRA+ et des populations de cellules souches mésenchymateuses (MSC), ainsi que des méthodes de fabrication et d'utilisation de celles-ci pour traiter une encéphalopathie hypoxique-ischémique (HIE) ou une lésion cérébrale chez un sujet.